You have 9 free searches left this month | for more free features.

azacitidine

Showing 1 - 25 of 262

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

High Grade MDS Trial in Aurora (Omacetaxine, Azacitidine)

Recruiting
  • High Grade Myelodysplastic Syndromes
  • Aurora, Colorado
    Universtiy of Colorado Denver
Oct 19, 2021

MDS Trial in Saint Louis (vosaroxin, Azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 23, 2022

Acute Kidney Disease Trial in Taipei City (Azacitidine, Placebo)

Not yet recruiting
  • Acute Kidney Disease
  • Azacitidine
  • Placebo
  • Taipei City, Taiwan
    Yu Hsiang Chou
May 2, 2022

Myeloid Malignancy Trial in Detroit (azacitidine)

Recruiting
  • Myeloid Malignancy
  • azacitidine
  • Detroit, Michigan
    Henry ford hospital
Dec 23, 2021

Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Relapsed Adult AML
  • Lintuzumab-Ac225
  • +2 more
  • (no location specified)
Feb 22, 2022

Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Aurora, Colorado
    Universtiy of Colorado Hospital
Feb 15, 2022

Higher Risk Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia Trial (AMG 176, Azacitidine)

Not yet recruiting
  • Higher Risk Myelodysplastic Syndrome
  • Chronic Myelomonocytic Leukemia
  • AMG 176
  • Azacitidine
  • (no location specified)
Jul 29, 2022

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Venetoclax)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Jul 22, 2022

Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Myelofibroses
  • Chicago, Illinois
    The University of Chicago
May 16, 2022

Myelodysplastic Syndrome (MDS) Trial (FF-10501-01, Azacitidine)

Withdrawn
  • Myelodysplastic Syndrome (MDS)
  • (no location specified)
Jul 20, 2021

MDS Trial (Pevonedistat, Azacitidine)

No longer available
  • Myelodysplastic Syndromes
  • (no location specified)
Sep 8, 2021

Leukemia, Myeloid, Acute Trial in Guanzhou (Azacitidine, Chidamide)

Recruiting
  • Leukemia, Myeloid, Acute
  • Guanzhou, Guandong, China
    Nanfang Hospital of Southern Medical University
Mar 6, 2022

Pancreas Cancer Trial in New York (Pembrolizumab, Azacitidine)

Active, not recruiting
  • Pancreas Cancer
  • New York, New York
    Columbia University Irving Medical Center
Oct 20, 2021

Secondary Myelodysplastic Syndrome, Therapy-Related Myelodysplastic Syndrome Trial in Columbus (Azacitidine, Quality-of-Life

Recruiting
  • Secondary Myelodysplastic Syndrome
  • Therapy-Related Myelodysplastic Syndrome
  • Azacitidine
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jul 6, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 28, 2022

Acute Myeloid Leukemia Trial in Sacramento (Azacitidine, Uproleselan, Venetoclax)

Recruiting
  • Acute Myeloid Leukemia
  • Azacitidine
  • +2 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Aug 12, 2022

Acute Myeloid Leukemia Trial in United States (Cytarabine, Idarubicin, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Duarte, California
  • +4 more
Aug 3, 2022

Relapsed/Refractory Peripheral T-cell Lymphoma Trial in Suzhou (Anti-PD-1 mAb, Lenalidomide, Azacitidine)

Recruiting
  • Relapsed/Refractory Peripheral T-cell Lymphoma
  • Anti-PD-1 monoclonal antibody
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 21, 2021

MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Nov 29, 2021

Philadelphia Chromosome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Suzhou (Azacitidine, Venetoclax,

Recruiting
  • Philadelphia Chromosome
  • +4 more
  • Azacitidine
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jun 23, 2022

MDS, Myeloproliferative Tumor, Acute Myeloid Leukemia Trial in Cleveland (Azacitidine, Ascorbic acid)

Completed
  • Myelodysplastic Syndromes
  • +2 more
  • Azacitidine
  • Ascorbic acid
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Aug 4, 2021

Acute Myeloid Leukemia, AML, Adult Trial in United States (evorpacept, venetoclax, azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • AML, Adult
  • Chicago, Illinois
  • +4 more
Jun 7, 2022

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
May 23, 2022

Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia-0
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Azacitidine
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021